BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25641920)

  • 1. Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.
    Liu Y; Luo Y; Li X; Zheng W; Chen T
    Chem Asian J; 2015 Mar; 10(3):642-52. PubMed ID: 25641920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways.
    Zhao J; Zeng D; Liu Y; Luo Y; Ji S; Li X; Chen T
    Metallomics; 2017 May; 9(5):535-545. PubMed ID: 28374040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
    Yang Y; Deng S; Zeng Q; Hu W; Chen T
    Dalton Trans; 2016 Nov; 45(46):18465-18475. PubMed ID: 27711726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
    Liang Y; Zhou Y; Deng S; Chen T
    ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways.
    Xie Q; Zhou Y; Lan G; Yang L; Zheng W; Liang Y; Chen T
    Biochem Biophys Res Commun; 2014 Jun; 449(1):88-93. PubMed ID: 24813998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
    Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I; Pollak Y; Broneshter R; Iancu TC
    FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin induced apoptosis was potentiated by neferine in human lung adenocarcima, A549 cells.
    Poornima P; Kumar VB; Weng CF; Padma VV
    Food Chem Toxicol; 2014 Jun; 68():87-98. PubMed ID: 24632453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro anti-bacterial evaluation of tetracyclic-ortho-fused 4H-naphtho[1',2'-5,6]pyrano[3,4-d](1,2,3)selenadiazole and its derivatives.
    Karnik AV; Kulkarni AM; Malviya NJ; Mourya BR; Jadhav BL
    Eur J Med Chem; 2008 Nov; 43(11):2615-7. PubMed ID: 18339454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
    Datir SR; Das M; Singh RP; Jain S
    Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ; Du XJ; Mao CQ; Wang J
    J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
    Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
    Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening and assessment of anticancer potential of selenium-based compounds against HL-60 and MCF7 cells.
    Ferreira de Queiroz EF; de Sousa Luis JA; de Sousa Dantas D; Pereira Arruda LC; Cordeiro Bento da Silva E; de Sousa E Silva JM; da Silva Souza HD; Costa Barros RP; de Mascena Costa LA; de Athayde Filho PF; Scotti L; Scotti MT; Gomes Filho MA
    Future Med Chem; 2020 Dec; 12(24):2191-2207. PubMed ID: 33243002
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives).
    Hayat F; Salahuddin A; Zargan J; Azam A
    Eur J Med Chem; 2010 Dec; 45(12):6127-34. PubMed ID: 20961670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized Multiwalled Carbon Nanotubes as Carriers of Ruthenium Complexes to Antagonize Cancer Multidrug Resistance and Radioresistance.
    Wang N; Feng Y; Zeng L; Zhao Z; Chen T
    ACS Appl Mater Interfaces; 2015 Jul; 7(27):14933-45. PubMed ID: 26107995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.